logo
Mini Focus
Analytical and bioanalytical assay challenges to support comparability studies for biosimilar drug development
European perspective on biosimilars
Biomarker agreement entered into by Verastem and Laboratory Corporation of America® Holdings
MacroGenics and Gilead Sciences to form new antibody alliance
Increased accessibility of next-generation sequencing?
Launch of a US$5 million Parkinson’s Disease Biomarkers Program in the USA
WILEX AG strikes deal with GeneDiagnostics over the serum HER-/neu ELISA test
Conference Report
A wide angle view of biosimilars from a bioanalytical perspective
Nonclinical development of a biosimilar
Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS
Assessing immunogenicity of biosimilar therapeutic monoclonal antibodies
Clinical development of biosimilars
Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin
Quantitative imaging of a therapeutic peptide in biological tissue sections by MALDI MS
Evaluation of dried blood spots for the quantification of therapeutic monoclonal antibodies and detection of anti-drug antibodies
Comparison of newly developed immuno-MS method with existing DELFIA® immunoassay for human chorionic gonadotropin determination in doping analysis
Acknowledgements